NCI is developing review criteria for a Cancer Center Loan Program that would provide $200 million in loans for capital improvements to qualified centers. NCAB member Eric Lander criticizes limited discussion, “lack of vision” for the loan program.
NCI Director asks NCAB to pray for him.
NCI prepares for third hearing on conflicts of interest.
Waxman urges drug companies to list clinical trials on NIH Web site.
NIH Chemical Genomics Center to screen small molecules.
Knudson wins Kyoto prize; King wins genetics prize.
Funding opportunities listed.
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies